The independent source for health policy research, polling, and news.
21 - 40 of 1,295 Results
With abortions still on the rise nationwide despite widespread bans, curtailing the use of pregnancy-terminating medication is a top priority for abortion opponents — and they’re frustrated that the Trump administration isn’t doing more to limit its use.
Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
KFF Health News' editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a collection of her appearances.
With lawmakers still mired over renewing enhanced tax credits for Affordable Care Act plans, much of Washington has turned to culture war issues. Meanwhile, “confusion” remains the watchword at HHS as personnel and funding decisions continue to be made and unmade with little notice. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews KFF Health News’ Elisabeth Rosenthal, who wrote the latest “Bill of the Month” report.
Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead. California and other states say the drugs are too costly, even as the Trump administration announces plans to lower prices.
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects.
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
Participants in an FDA panel discussion warned the public about risks from using antidepressants in pregnancy. But mental health issues, including suicide and overdoses, are the leading cause of maternal death in the United States. Antidepressants are a safe, well-studied way to help prevent those deaths, medical experts say.
A session of a vaccine panel dominated by skeptics was chaotically at odds with past practices of the CDC, which HHS Secretary Robert F. Kennedy Jr. has described as a “cesspool of corruption.” His crew voted to end a 34-year recommendation to vaccinate newborns against hepatitis B.
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
The record-long federal shutdown is over after a small group of Democrats agreed to a deal with most Republicans that funds the government through January — but, notably, does not extend more generous Affordable Care Act tax credits. Plus, new details are emerging about how the Trump administration is using the Medicaid program to advance its policy goals. Anna Edney of Bloomberg News, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews KFF Health News’ Julie Appleby, who wrote the latest “Bill of the Month” feature.
A standoff in Congress is keeping much of the government shut down as open enrollment begins in most states for Affordable Care Act plans. Democrats are demanding Republicans agree to extend ACA tax credits, but there has been little negotiating — even as customers are learning what they’ll pay for coverage next year. Meanwhile, the Trump administration is telling states they can’t pass their own laws to keep medical debt off consumers’ credit reports. Paige Winfield Cunningham of The Washington Post, Maya Goldman of Axios, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more.
California Gov. Gavin Newsom vetoed a bill that would have expanded access to hormone therapy, a top priority for the trans community. Advocates say it would have ensured continuity in gender-affirming care amid Trump administration attacks. Analysts say it’s another sign of the Democrat’s move to the center.
Democrats and Republicans remain stalled over funding the federal government as Republicans launch a new attack on the Affordable Care Act. Meanwhile, the Trump administration is taking advantage of the shutdown to lay off workers from programs supported mostly by Democrats. Anna Edney of Bloomberg News, Lauren Weber of The Washington Post, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews health insurance analyst Louise Norris about Medicare open enrollment.
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress — a potential tool for those with high trauma rates, like firefighters and police officers. Yet the drug’s stigma and unregulated marketplace leave first responders in uncharted territory.
On the "Today, Explained" podcast, KFF Health News' Julie Rovner recaps the TrumpRx announcement and why the direct-to-consumer initiative may not save you money on prescription drugs if you have insurance through your employer or the government.
Barbara Kingsolver won a Pulitzer Prize for her bestselling novel about Appalachia’s drug crisis. She invested some of the proceeds into a home for women trying to beat substance use disorders.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
© 2026 KFF